LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 55

Search options

  1. Article ; Online: Vitamin D deficiency and rickets in children and adolescents with ichthyosiform erythroderma in type IV and V skin.

    Chouhan, K / Sethuraman, G / Gupta, N / Sharma, V K / Kabra, M / Khaitan, B K / Sreenivas, V / Ramam, M / Kusumakar, S / Thulkar, S / Paller, A S

    The British journal of dermatology

    2012  Volume 166, Issue 3, Page(s) 608–615

    Abstract: Background: Ichthyosiform erythroderma due to keratinizing disorders may suppress cutaneous vitamin D synthesis, leading to vitamin D deficiency and rickets.: Objectives: To determine the prevalence of vitamin D deficiency and rickets in children and ...

    Abstract Background: Ichthyosiform erythroderma due to keratinizing disorders may suppress cutaneous vitamin D synthesis, leading to vitamin D deficiency and rickets.
    Objectives: To determine the prevalence of vitamin D deficiency and rickets in children and adolescents with congenital ichthyosis and other keratinizing disorders with erythroderma and scaling.
    Patients and methods: In this cross-sectional study, 45 children and adolescents with ichthyosiform erythroderma due to keratinizing disorders, and 66 controls (group 1: age and sex matched, with skin diseases other than keratinizing disorders; group 2: age and sex matched, healthy volunteers) were included. Evidence of rickets was determined clinically (physical examination and radiographs) and biochemically {serum calcium, phosphorus, alkaline phosphatase, 25-hydroxy vitamin D [25(OH)D] and parathyroid hormone (PTH)}.
    Results: All patients in the disease group had clinical, radiological or biochemical evidence of rickets [25(OH)D<20ngmL(-1) ], and analysis was done for all subjects with the available biochemical reports. The mean serum 25(OH)D levels of the disease group was 8·38±5·23ngmL(-1) and was significantly lower than in control group 1 (11·1±5·8ngmL(-1) ) (P<0·01) and control group 2 (13·5±6·9ngmL(-1) ) (P<0·001). The prevalence of vitamin D deficiency [25(OH)D<20ngmL(-1) ] was significantly higher in the disease group (n=38 of 39, 97·4%) than in control group 2 (n=12, 70·6%) (P<0·01), and total controls (n=56, 84·8%) (P=0·04). The frequency of hyperparathyroidism (PTH>65pgmL(-1) ) was also significantly higher in the disease group than in controls (P<0·01).
    Conclusions: Children and adolescents with various forms of ichthyosiform erythroderma, especially those with pigmented skin (types IV-VI), are at increased risk of developing vitamin D deficiency and clinical rickets.
    MeSH term(s) Adolescent ; Alkaline Phosphatase/metabolism ; Calcium/metabolism ; Child ; Cross-Sectional Studies ; Female ; Humans ; Ichthyosiform Erythroderma, Congenital/blood ; Ichthyosiform Erythroderma, Congenital/complications ; Male ; Parathyroid Hormone/metabolism ; Phosphorus/metabolism ; Rickets/blood ; Rickets/etiology ; Vitamin D/analogs & derivatives ; Vitamin D/metabolism ; Vitamin D Deficiency/blood ; Vitamin D Deficiency/etiology
    Chemical Substances Parathyroid Hormone ; Vitamin D (1406-16-2) ; Phosphorus (27YLU75U4W) ; 25-hydroxyvitamin D (A288AR3C9H) ; Alkaline Phosphatase (EC 3.1.3.1) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2012-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1111/j.1365-2133.2011.10672.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.

    Kusumakar, Vivek

    The Journal of clinical psychiatry

    2002  Volume 63 Suppl 10, Page(s) 23–28

    Abstract: Antidepressants and antipsychotics are frequently used as mood stabilizers in the treatment of bipolar disorder. As common as these agents appear to be in bipolar treatment, the literature contains little research on their efficacy and safety in the long ...

    Abstract Antidepressants and antipsychotics are frequently used as mood stabilizers in the treatment of bipolar disorder. As common as these agents appear to be in bipolar treatment, the literature contains little research on their efficacy and safety in the long term. Most of the available literature on long-term antidepressant treatment focuses on tricyclic antidepressants, which have been shown to induce mania or hypomania. Rapid cycling is another side effect that is associated with antidepressant treatment in bipolar disorder. Antidepressants do not appear to be any more effective than mood stabilizers in treating bipolar depression. Conventional antipsychotics in depot formulations have been shown to be an effective treatment, but conventional antipsychotics may cause tardive dyskinesia. The novel antipsychotics clozapine, risperidone, and olanzapine appear to be efficacious; however, their side effect profiles include agranulocytosis and weight gain. Given the frequency with which antidepressants and antipsychotics are used in bipolar disorder and that bipolar disorder is a chronic disease requiring maintenance treatment, more research on the use of these types of agents in long-term treatment is needed. Until more evidence is available on the long-term treatment outcomes, clinicians should be aware that the adverse events associated with antidepressants and antipsychotics may outweigh the benefit, if any, of the use of these agents in bipolar disorder.
    MeSH term(s) Agranulocytosis/chemically induced ; Antidepressive Agents/adverse effects ; Antidepressive Agents/therapeutic use ; Antipsychotic Agents/adverse effects ; Antipsychotic Agents/therapeutic use ; Bipolar Disorder/chemically induced ; Bipolar Disorder/drug therapy ; Bipolar Disorder/prevention & control ; Bipolar Disorder/psychology ; Clinical Trials as Topic ; Clozapine/adverse effects ; Clozapine/therapeutic use ; Delayed-Action Preparations ; Double-Blind Method ; Drug Administration Schedule ; Drug Therapy, Combination ; Humans ; Long-Term Care ; Treatment Outcome ; Weight Gain
    Chemical Substances Antidepressive Agents ; Antipsychotic Agents ; Delayed-Action Preparations ; Clozapine (J60AR2IKIC)
    Language English
    Publishing date 2002
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 716287-x
    ISSN 1555-2101 ; 0160-6689
    ISSN (online) 1555-2101
    ISSN 0160-6689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline.

    Pardeshi, Chandrakantsing V / Agnihotri, Vinit V / Patil, Kusumakar Y / Pardeshi, Sagar R / Surana, Sanjay J

    International journal of biological macromolecules

    2020  Volume 165, Issue Pt A, Page(s) 445–459

    Abstract: Drug delivery to lungs via pulmonary administration offers potential for the development of new drug delivery systems. Here we fabricated the etofylline (ETO) encapsulated mannose-anchored N,N,N-trimethyl chitosan nanoparticles (Mn-TMC NPs). The ... ...

    Abstract Drug delivery to lungs via pulmonary administration offers potential for the development of new drug delivery systems. Here we fabricated the etofylline (ETO) encapsulated mannose-anchored N,N,N-trimethyl chitosan nanoparticles (Mn-TMC NPs). The prominent characteristics like biocompatibility, controlled release, targeted delivery, high penetrability, enhanced physical stability, and scalability mark Mn-TMC NPs as a viable alternative to various nanoplatform technologies for effective drug delivery. Mannosylation of TMC NPs leads to the evolution of new drug delivery vehicle with gratifying characteristics, and potential benefits in efficient drug therapy. It is widely accepted that following pulmonary administration, the introduction of mannose to the surface of drug nanocarriers provide selective macrophage targeting via receptor-mediated endocytosis. The fabricated Mn-TMC NPs exhibited particle size of 223.3 nm, PDI 0.490, and ζ-potential -19.1 mV, drug-loading capacity 76.26 ± 1.2%, and encapsulation efficiency of 91.75 ± 0.88%. Sustained drug release, biodegradation studies, stability, safety, and aerodynamic behavior revealed the effectiveness of prepared nanoformulation for pulmonary administration. In addition, the in vivo pharmacokinetic studies in Wistar rat model revealed a significant improvement in therapeutic efficacy of ETO, illustrating mannosylation a promising approach for efficient therapy of airway diseases following pulmonary administration.
    MeSH term(s) Animals ; Chitosan/chemistry ; Chitosan/pharmacokinetics ; Chitosan/pharmacology ; Drug Carriers/chemistry ; Drug Carriers/pharmacokinetics ; Drug Carriers/pharmacology ; Lung Diseases/drug therapy ; Lung Diseases/metabolism ; Lung Diseases/pathology ; Male ; Mannose/chemistry ; Mannose/pharmacokinetics ; Nanoparticles/chemistry ; Nanoparticles/therapeutic use ; Rats ; Rats, Wistar ; Theophylline/analogs & derivatives ; Theophylline/chemistry ; Theophylline/pharmacokinetics ; Theophylline/pharmacology
    Chemical Substances Drug Carriers ; N-trimethyl chitosan chloride ; Chitosan (9012-76-4) ; Theophylline (C137DTR5RG) ; etofylline (L164909TBI) ; Mannose (PHA4727WTP)
    Language English
    Publishing date 2020-09-25
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 282732-3
    ISSN 1879-0003 ; 0141-8130
    ISSN (online) 1879-0003
    ISSN 0141-8130
    DOI 10.1016/j.ijbiomac.2020.09.163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline

    Pardeshi, Chandrakantsing V / Agnihotri, Vinit V / Patil, Kusumakar Y / Pardeshi, Sagar R / Surana, Sanjay J

    International journal of biological macromolecules. 2020 Dec. 15, v. 165

    2020  

    Abstract: Drug delivery to lungs via pulmonary administration offers potential for the development of new drug delivery systems. Here we fabricated the etofylline (ETO) encapsulated mannose-anchored N,N,N-trimethyl chitosan nanoparticles (Mn-TMC NPs). The ... ...

    Abstract Drug delivery to lungs via pulmonary administration offers potential for the development of new drug delivery systems. Here we fabricated the etofylline (ETO) encapsulated mannose-anchored N,N,N-trimethyl chitosan nanoparticles (Mn-TMC NPs). The prominent characteristics like biocompatibility, controlled release, targeted delivery, high penetrability, enhanced physical stability, and scalability mark Mn-TMC NPs as a viable alternative to various nanoplatform technologies for effective drug delivery. Mannosylation of TMC NPs leads to the evolution of new drug delivery vehicle with gratifying characteristics, and potential benefits in efficient drug therapy. It is widely accepted that following pulmonary administration, the introduction of mannose to the surface of drug nanocarriers provide selective macrophage targeting via receptor-mediated endocytosis. The fabricated Mn-TMC NPs exhibited particle size of 223.3 nm, PDI 0.490, and ζ-potential −19.1 mV, drug-loading capacity 76.26 ± 1.2%, and encapsulation efficiency of 91.75 ± 0.88%. Sustained drug release, biodegradation studies, stability, safety, and aerodynamic behavior revealed the effectiveness of prepared nanoformulation for pulmonary administration. In addition, the in vivo pharmacokinetic studies in Wistar rat model revealed a significant improvement in therapeutic efficacy of ETO, illustrating mannosylation a promising approach for efficient therapy of airway diseases following pulmonary administration.
    Keywords aerodynamics ; animal models ; biocompatibility ; biodegradation ; chitosan ; drug therapy ; drugs ; encapsulation ; endocytosis ; evolution ; macrophages ; mannose ; mannosylation ; nanocarriers ; particle size ; pharmacokinetics
    Language English
    Dates of publication 2020-1215
    Size p. 445-459.
    Publishing place Elsevier B.V.
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 282732-3
    ISSN 1879-0003 ; 0141-8130
    ISSN (online) 1879-0003
    ISSN 0141-8130
    DOI 10.1016/j.ijbiomac.2020.09.163
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Effect of feeding water soaked rapeseed-mustard cake (Brassica juncea) based diet on the performance of lactating cows

    Palanivel, M / Sharma, Kusumakar

    Journal of dairying, foods & home sciences. 2016 Sept., v. 35, no. 3

    2016  

    Abstract: ... g DM and it gets reduced by 31.96 per cent to 101.72 μmol/g DM in overnight water soaked (1:3 w/v ...

    Abstract The study was carried out to ascertain the effect of feeding water soaked rapeseed-mustard cake (RMC) based diet on the performance of lactating cows. Eighteen Holstein Friesian crossbred lactating cows were randomly allocated to 3 dietary treatments of 6 each viz. Control, RMC-dry and RMC-sani, respectively for an experimental period of 90 days. The glucosinolates (GLS) content of raw RMC was 149.50 μmol/g DM and it gets reduced by 31.96 per cent to 101.72 μmol/g DM in overnight water soaked (1:3 w/v ratio) RMC. The daily intake of concentrate and total DM by lactating cows did not differ significantly (P>0.05) irrespective of the dietary treatments. The digestibility coefficient (%) of DM, OM, CP, EE, NDF and ADF; nutrient density (%) and intake (g/kgW⁰.⁷⁵) of composite diets in terms of DCP and TDN did not differ significantly (P>0.05) irrespective of dietary treatments. Milk yield and its basic quality parameters including milk fat, milk protein, total solids and SNF content were comparable among the dietary treatments. Though thiocyanate (CNS) concentration of blood serum (8.65 to 12.65 μg/ml) and milk (24.77 to 39.84 μg/ml) was significantly (P<0.01) increased in RMC fed groups as compared to control, it was significantly (P<0.01) reduced in RMC-sani as compared to RMC-dry. The serum T₃ (2.07 - 2.15 nmol/L) and T₄ (70.62 - 73.67 nmol/L) concentrations were comparable among the dietary treatments. Alongwith substantial reduction in the GLS content of water soaked RMC, no adverse effect could be noticed by feeding raw or water soaked RMC based diet on the performance of lactating cows and CNS excretion in the body fluids get reduced by dose dependent intake of dietary GLS.
    Keywords Brassica juncea ; Holstein ; adverse effects ; blood serum ; cow feeding ; crossbreds ; digestibility ; dose response ; excretion ; glucosinolates ; lactating females ; lactation ; milk ; milk fat ; milk proteins ; milk yield ; mustard oil cake ; nutrient density ; rapeseed cake ; thiocyanates ; total solids
    Language English
    Dates of publication 2016-09
    Size p. 201-205.
    Publishing place Agricultural Research Communication Centre
    Document type Article
    ZDB-ID 1154792-3
    ISSN 0976-0563 ; 0253-6595 ; 0971-4456
    ISSN (online) 0976-0563
    ISSN 0253-6595 ; 0971-4456
    DOI 10.18805/ajdfr.v3i1.3572
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: Choline in pediatric depression.

    MacMaster, Frank P / Kusumakar, Vivek

    McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students

    2009  Volume 9, Issue 1, Page(s) 24–27

    Abstract: Purpose of study: The prefrontal cortex has been previously implicated in the neuropathology of major depressive disorder (MDD). Hence, we used proton magnetic resonance spectroscopy (1H-MRS) to examine choline levels in the prefrontal cortex of youth ... ...

    Abstract Purpose of study: The prefrontal cortex has been previously implicated in the neuropathology of major depressive disorder (MDD). Hence, we used proton magnetic resonance spectroscopy (1H-MRS) to examine choline levels in the prefrontal cortex of youth with major depression.
    Basic procedures: Twelve age- and sex-matched case-control pairs were examined (age range 10 to 18 years, 7 females and 5 males in each group). All subjects were treatment naive at the time of the scan. A long echo 1H-MRS scan was acquired from the right prefrontal cortex (4cc) in all subjects.
    Main findings: Right prefrontal Choline/Creatine ratios were elevated in the youth with mood disorders (F1, 11=10.741, p=0.007) as compared with healthy controls.
    Principal conclusions: These findings suggest that prefrontal cytosolic choline may be increased in youth with MDD in comparison with healthy controls. This is consistent with reported findings in both adults and adolescents and suggests that MDD in youth is associated with alterations in choline metabolism in the prefrontal cortex.
    Language English
    Publishing date 2009-06-04
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 1433496-3
    ISSN 1715-8125 ; 1201-026X
    ISSN (online) 1715-8125
    ISSN 1201-026X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Open trial of interpersonal therapy in adolescents with moderate to severe major depression: effectiveness of novice IPT therapists.

    Santor, D A / Kusumakar, V

    Journal of the American Academy of Child and Adolescent Psychiatry

    2001  Volume 40, Issue 2, Page(s) 236–240

    Abstract: Objective: To evaluate the effectiveness of interpersonal therapy (IPT) implemented by well-supervised, novice IPT therapists in treating adolescents with moderate to severe mood disorders of lengthy duration.: Method: Twenty-five adolescents with ... ...

    Abstract Objective: To evaluate the effectiveness of interpersonal therapy (IPT) implemented by well-supervised, novice IPT therapists in treating adolescents with moderate to severe mood disorders of lengthy duration.
    Method: Twenty-five adolescents with moderate to severe major depression, lasting an average of 8 months, received 12 weeks of IPT. All participants were assessed with the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, the Beck Depression Inventory (BDI), the Hamilton Rating Scale for Depression (HRSD), and the Children's Global Assessment Scale (C-GAS) at baseline and follow-up.
    Results: The majority of participants improved substantially on the BDI, the HRSD, and the C-GAS; 84% met remission criteria on the HRSD (score < 7); and 80% met remission criteria on the BDI (score < 10).
    Conclusions: Results demonstrate that IPT is effective in treating moderately to severely depressed adolescents, that IPT is effective with depression lasting several months, and that IPT can be effectively implemented by well-supervised clinicians with no prior training in IPT.
    MeSH term(s) Adolescent ; Depressive Disorder/therapy ; Female ; Humans ; Male ; Nova Scotia ; Psychotherapy, Brief/education ; Psychotherapy, Brief/methods ; Severity of Illness Index ; Treatment Outcome
    Language English
    Publishing date 2001-02
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 392535-3
    ISSN 1527-5418 ; 0890-8567
    ISSN (online) 1527-5418
    ISSN 0890-8567
    DOI 10.1097/00004583-200102000-00019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Long-term Effects of Feeding a Novel Phytoadditive on Nutrient Utilization, Growth Performance, Metabolic Profile and Antioxidant Status of Goats

    Ingale, Santosh L / Ashok K. Pattanaik / Shalini Baliyan / Sarita Kankoriya / Narayan Dutta / Kusumakar Sharma

    Agricultural research. 2017 Mar., v. 6, no. 1

    2017  

    Abstract: The present study was undertaken to ascertain the health-promoting effects of a phytoadditive (PA) having confirmed in vitro antimethanogenic potential. The PA was prepared by mixing fixed proportions of Withania somnifera, Boerhavia diffusa and ... ...

    Abstract The present study was undertaken to ascertain the health-promoting effects of a phytoadditive (PA) having confirmed in vitro antimethanogenic potential. The PA was prepared by mixing fixed proportions of Withania somnifera, Boerhavia diffusa and Holarrhena antidysenterica. Eighteen Jamunapari kids of three months of age were used in a 180-day study. The kids were divided into three equal groups and supplemented with the PA at 0 (PA-0), 1.5 (PA-1.5) and 2.5 (PA-2.5) percent of expected mean daily feed (DM) intake. A metabolism trial conducted following 180-days of feeding trial indicated no variations (P > 0.05) in intake and digestibility of organic nutrients. The plane of nutrition and nitrogen retention was also similar (P > 0.05) across the treatments. Blood collected at 30-days intervals was assessed for erythrocytic antioxidants and metabolic indices. The PA improved (P < 0.05) the erythrocytic lipid peroxidation, and activities of superoxide dismutase, catalase and glutathione peroxidase. The serum levels of glucose, urea, total protein, globulin and alanine aminotransferase remained similar (P > 0.05) among the groups, whereas serum levels of albumin were improved (P < 0.05) in the PA-supplemented groups with a reverse trend (P < 0.05) for total cholesterol. The serum aspartate aminotransferase activity was reduced (P < 0.05) in both the PA-groups. The dietary treatments imparted no difference (P > 0.05) on the average daily gain (g) which was 35 ± 4.0, 31 ± 3.4 and 34 ± 4.0 for the PA-0, PA-1.5 and PA-2.5 groups, respectively. The feed conversion ratio was also comparable across the dietary groups. Overall, it is concluded that while the dietary supplementation of the PA had no influence on the nutrient metabolism or growth, it did stimulate the antioxidant status of growing kids and thus possess potential to be of practical value in stressful management situations.
    Keywords Boerhavia diffusa ; Holarrhena pubescens ; Withania somnifera ; alanine transaminase ; albumins ; antioxidants ; aspartate transaminase ; average daily gain ; blood serum ; catalase ; cholesterol ; digestibility ; feed conversion ; feeding level ; globulins ; glucose ; glutathione peroxidase ; goats ; growth performance ; health promotion ; lipid peroxidation ; long term effects ; metabolism ; mixing ; nitrogen ; nutrients ; protein content ; superoxide dismutase ; urea
    Language English
    Dates of publication 2017-03
    Size p. 82-90.
    Publishing place Springer India
    Document type Article
    ZDB-ID 2668414-7
    ISSN 2249-7218 ; 2249-720X
    ISSN (online) 2249-7218
    ISSN 2249-720X
    DOI 10.1007/s40003-017-0245-y
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article: Lamotrigine treatment of rapid cycling bipolar disorder.

    Kusumakar, V / Yatham, L N

    The American journal of psychiatry

    1997  Volume 154, Issue 8, Page(s) 1171–1172

    MeSH term(s) Adult ; Aged ; Anticonvulsants/therapeutic use ; Bipolar Disorder/drug therapy ; Drug Administration Schedule ; Drug Eruptions/etiology ; Drug Therapy, Combination ; Humans ; Lamotrigine ; Triazines/therapeutic use ; Valproic Acid/therapeutic use
    Chemical Substances Anticonvulsants ; Triazines ; Valproic Acid (614OI1Z5WI) ; Lamotrigine (U3H27498KS)
    Language English
    Publishing date 1997-07-01
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 280045-7
    ISSN 1535-7228 ; 0002-953X
    ISSN (online) 1535-7228
    ISSN 0002-953X
    DOI 10.1176/ajp.154.8.1171b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: An open study of lamotrigine in refractory bipolar depression.

    Kusumakar, V / Yatham, L N

    Psychiatry research

    1997  Volume 72, Issue 2, Page(s) 145–148

    Abstract: Bipolar depressed patients (n = 22) who were refractory to treatment with a combination of divalproex sodium (DVP) and another mood stabilizer or DVP and an antidepressant for 6 weeks were treated in an open naturalistic study with an addition of ... ...

    Abstract Bipolar depressed patients (n = 22) who were refractory to treatment with a combination of divalproex sodium (DVP) and another mood stabilizer or DVP and an antidepressant for 6 weeks were treated in an open naturalistic study with an addition of lamotrigine to DVP. Sixteen out of 22 (72%) responded by the end of week 4 and none developed rash or switched to mania. The results of this preliminary study suggest that lamotrigine may be useful in bipolar depression.
    MeSH term(s) Adolescent ; Adult ; Anticonvulsants/administration & dosage ; Anticonvulsants/adverse effects ; Antidepressive Agents/administration & dosage ; Antidepressive Agents/adverse effects ; Bipolar Disorder/drug therapy ; Bipolar Disorder/psychology ; Cohort Studies ; Depressive Disorder/drug therapy ; Depressive Disorder/psychology ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Humans ; Lamotrigine ; Male ; Personality Inventory ; Psychiatric Status Rating Scales ; Treatment Outcome ; Triazines/administration & dosage ; Triazines/adverse effects ; Valproic Acid/administration & dosage ; Valproic Acid/adverse effects
    Chemical Substances Anticonvulsants ; Antidepressive Agents ; Triazines ; Valproic Acid (614OI1Z5WI) ; Lamotrigine (U3H27498KS)
    Language English
    Publishing date 1997-09-19
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 445361-x
    ISSN 1872-7123 ; 1872-7506 ; 0165-1781 ; 0925-4927
    ISSN (online) 1872-7123 ; 1872-7506
    ISSN 0165-1781 ; 0925-4927
    DOI 10.1016/s0165-1781(97)00082-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top